3M · Earnings release · 8-K Exhibit 99

3M Delivers Strong Third-Quarter Results; Increases Full-Year Margin and EPS Guidance

•GAAP sales of $6.5 billion, up 3.5%; operating margin 22.2%, up 130 bps; EPS of $1.55, down 38%, all YoY

◦T1Adjusted sales of $6.3 billion with organic growth of 3.2% YoY

◦Adjusted operating margin of 24.7%, up 170 bps YoY

◦Adjusted EPS of $2.19, up 10% YoY

•Operating cash flow of $1.8 billion with adjusted free cash flow of $1.3 billion

ST. PAUL, Minn. – October 21, 2025 − 3M (NYSE: MMM) today reported third-quarter 2025 results.

“I am very pleased with our teams’ focus on reinvigorating organic top-line growth and improving operational performance resulting in another strong quarter,” said William Brown, 3M Chairman and CEO. "The 3M excellence model helped accelerate organic sales growth, increase margins, grow EPS double-digits and generate robust free cash flow. This progress gives us the confidence to raise our full-year margin and EPS guidance which positions us well to achieve the strategic and financial commitments we made at our Investor Day earlier this year.”

Third-quarter highlights:

GAAP EPS from continuing operations (GAAP EPS)

$

$

Special items:

Net costs for significant litigation

(Increase) decrease in value of Solventum ownership

Manufactured PFAS products

—

Loss on business divestitures

—

Transformation costs

—

Adjusted EPS from continuing operations (adjusted EPS)

$

$

Memo:

GAAP operating income margin

%

%

Adjusted operating income margin

%

%

•GAAP EPS of $1.55 and operating margin of 22.2%.

•Adjusted EPS of $2.19, up 10% year-on-year.

•T3Adjusted operating income margin of 24.7%, an increase of 170 basis points year-on-year.

GAAP

Adjusted (non-GAAP)

Net sales (billions)

Sales change

Total sales

Components of sales change:

Organic sales

Acquisitions/divestitures

Translation

T4Adjusted sales excludes manufactured PFAS products.

•Sales of $6.5 billion, up 3.5% year-on-year with organic sales up 2.6% year-on-year.

•Adjusted sales of $6.3 billion, up 4.1% year-on-year with adjusted organic sales up 3.2% year-on-year.

•T53M returned $0.9 billion to shareholders via dividends and share repurchases.

•Cash from operations of $1.8 billion.

•T6Adjusted free cash flow of $1.3 billion.

This document includes reference to certain non-GAAP measures. See the “Supplemental Financial Information Non-GAAP Measures” section for applicable information.

1

Updated full-year guidance

3M updated its full-year 2025 guidance given the company’s performance in the first nine months of the year.

•G2G3Adjusted total sales growth1 of >2.5 percent, reflecting adjusted organic sales growth1 of >2 percent.

•G4Adjusted operating income margin expansion1 of 180 bps to 200 bps.

•G5G6Adjusted operating cash flow1 of $5.2 to $5.4 billion, contributing to >100 percent adjusted free cash flow conversion1.

1As further discussed at 4 within the "Supplemental Financial Information Non-GAAP Measures" sections, 3M cannot, without unreasonable effort, forecast certain items required to develop meaningful comparable GAAP financial measures and, therefore, does not provide them on a forward-looking basis reflecting these items.

Conference call

3M will conduct an investor teleconference at 9 a.m. ET (8 a.m. CT) today. Investors can access this conference via the following:

•Live webcast at https://investors.3M.com

•Webcast replay at https://investors.3m.com/financials/quarterly-earnings

2

Forward-looking statements

This document contains forward-looking statements. You can identify these statements by the use of words such as “plan,” “expect,” “aim,” “believe,” “project,” “target,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could,” “would,” “forecast,” “future,” “outlook,” “guidance” and other words and terms of similar meaning. Forward-looking statements are based on certain assumptions and expectations of future events and trends that are subject to risks and uncertainties. Actual future results and trends may differ materially from historical results or those reflected in any such forward-looking statements depending on a variety of factors. Among the factors that could cause actual results to differ materially are the following: (1) T7worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions and other factors beyond the Company's control, including inflation; recession; military conflicts; trade restrictions such as sanctions, tariffs, reciprocal and retaliatory tariffs, and other tariff-related measures; regulatory requirements, legal actions, or enforcement; and natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) foreign currency exchange rates and fluctuations in those rates; (3) liabilities and the outcome of contingencies related to certain fluorochemicals; known as “PFAS,” including liabilities related to claims, lawsuits, and government regulatory proceedings concerning various PFAS-related products and chemistries, as well as risks related to the Company’s plans to exit PFAS manufacturing and work to discontinue use of PFAS across its product portfolio; (4) risks related to the class-action settlement (“PWS Settlement”) to resolve claims by public water suppliers in the United States regarding PFAS, as well as risks related to other settlements related to PFAS; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's reports on Form 10-K, 10-Q, and 8-K (Reports), as well as compliance risks related to legal or regulatory requirements, government contract requirements, policies and practices, or other matters that require or encourage the Company or its customers, suppliers, vendors, or channel partners to conduct business in a certain way; (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product and service offerings; (8) the availability and cost of purchased components, compounds, raw materials and energy due to shortages, increased demand and wages, tariffs, supply chain interruptions, or natural or other disasters; (9) unanticipated problems or delays when implementing new business systems and solutions, including with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information or operational technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other strategic events resulting from portfolio management actions and other evolving business strategies; (11) operational execution, including the extent to which the Company can realize the benefits of planned productivity improvements, as well as the impact of organizational restructuring activities; (12) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; (14) tax-related external conditions, including changes in tax rates, laws or regulations; (15) matters relating to the spin-off of the Company’s Health Care business, including the risk that the expected benefits will not be realized; the risk that the costs or dis-synergies will exceed the anticipated amounts; potential impacts on the Company's relationships with its customers, suppliers, employees, regulators and other counterparties; the ability to realize the desired tax treatment; risks under the agreements and obligations entered into in connection with the spin-off; and (16) matters relating to Combat Arms Earplugs (“CAE”) and related products, including those related to, the August 2023 settlement that is intended to resolve, to the fullest extent possible, all litigation and alleged claims involving the CAE sold or manufactured by the Company’s subsidiary Aearo Technologies and certain of its affiliates (“Aearo Entities”) and/or the Company (“CAE Settlement”).

A further description of these factors is located in the Reports under “Cautionary Note Concerning Factors That May Affect Future Results” and “Risk Factors” in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such assumptions or factors could produce significantly different results. The Company assumes no obligation to update any forward-looking statements discussed herein as a result of new information or future events or developments.

3

3M Company and Subsidiaries

CONSOLIDATED STATEMENT OF INCOME

(Millions, except per-share amounts)

(Unaudited)

Three months ended

Nine months ended

Net sales

$

$

$

$

Operating expenses

Cost of sales

Selling, general and administrative expenses

Research, development and related expenses

Loss on business divestitures

—

—

Total operating expenses

Operating income

Other expense (income), net

Income from continuing operations before income taxes

Provision for income taxes

Income from continuing operations of consolidated group

Income from unconsolidated subsidiaries, net of taxes

2

3

7

Net income from continuing operations including noncontrolling interest

Less: net income attributable to noncontrolling interest

7

4

Net income from continuing operations attributable to 3M

Net income from discontinued operations, net of taxes

—

—

—

Net income attributable to 3M

$

$

$

$

Earnings per share attributable to 3M common shareholders:

Weighted average 3M common shares outstanding — basic

Earnings per share from continuing operations — basic

$

$

$

$

Earnings per share from discontinued operations — basic

—

—

—

Earnings per share — basic

$

$

$

$

Weighted average 3M common shares outstanding — diluted

Earnings per share from continuing operations — diluted

$

$

$

$

Earnings per share from discontinued operations — diluted

—

—

—

Earnings per share — diluted

$

$

$

$

4

3M Company and Subsidiaries

CONDENSED CONSOLIDATED BALANCE SHEET

(Dollars in millions)

(Unaudited)

Assets

Current assets

Cash and cash equivalents

$

$

Marketable securities – current

Accounts receivable – net

Inventories

Prepaids

Assets held for sale

—

Other current assets

Total current assets

Property, plant and equipment – net

Operating lease right of use assets

Goodwill and intangible assets – net

Other assets

Total assets

$

$

Liabilities and equity

Current liabilities

Short-term borrowings and current portion of long-term debt

$

$

Accounts payable

Accrued payroll

Accrued income taxes

Operating lease liabilities – current

Liabilities held for sale

—

Other current liabilities

Total current liabilities

Long-term debt

Other liabilities

Total liabilities

Total equity

Shares outstanding

Total liabilities and equity

$

$

5

3M Company and Subsidiaries

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Dollars in millions)

(Unaudited)

Nine months ended September 30,

Net cash provided by (used in) operating activities

$

$

1

Cash flows from investing activities:

Purchases of property, plant and equipment

Purchases and proceeds from sale or maturities of marketable securities and investments – net

Proceeds from sale of businesses, net of cash sold

5

—

Other investing activities

Net cash provided by (used in) investing activities

Cash flows from financing activities:

Change in debt – net

Purchases of treasury stock

Proceeds from issuances of treasury stock pursuant to stock option and benefit plans

Dividends paid to shareholders

Cash transferred to Solventum related to separation, net

—

Other financing activities

Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents

(2)

Net increase (decrease) in cash and cash equivalents, including cash classified within assets held for sale

Less: net increase (decrease) in cash classified within assets held for sale

—

Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents at beginning of year

Cash and cash equivalents at end of period

$

$

The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.

6

3M Company and Subsidiaries

SALES CHANGE2

(Unaudited)

Total company sales change by geographic area

Americas

Asia Pacific

Europe, Middle East and Africa

Worldwide

Organic sales

%

%

%

%

Divestitures

—

—

Translation

Total sales change

%

%

%

%

Total company sales change by geographic area

Americas

Asia Pacific

Europe, Middle East and Africa

Worldwide

Organic sales

%

%

%

%

Divestitures

Translation

—

Total sales change

%

%

%

%

Sales change by reportable business segment

Organic sales

Divestitures

Translation

Total sales

change

Safety and Industrial

%

—

%

%

%

Transportation and Electronics

Consumer

—

Sales change by reportable business segment

Organic sales

Divestitures

Translation

Total sales

change

Safety and Industrial

%

—

%

%

%

Transportation and Electronics

Consumer

—

2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales, acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.

7

3M Company and Subsidiaries

BUSINESS SEGMENTS

(Unaudited)

3M discloses business segment operating income as its measure of segment profit, reconciled to both total 3M operating income and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to business segments (as described below in “Corporate and Other”).

Three months ended

Nine months ended

Net sales (millions)

Abrasives

$

$

$

$

Automotive Aftermarket

Electrical Markets

Industrial Adhesives and Tapes

Industrial Specialties Division

Personal Safety

Roofing Granules

Total Safety and Industrial business segment

Advanced Materials

Automotive and Aerospace

Commercial Branding and Transportation

Electronics

Total Transportation and Electronics business segment

Consumer Safety and Well-Being

Home and Auto Care

Home Improvement

Packaging and Expression

Total Consumer business segment

Total reportable business segments

Corporate and Other

Total company

$

$

$

$

Operating income (millions)

Safety and Industrial

$

$

$

$

Transportation and Electronics

Consumer

Total reportable business segments

Corporate and Other

Corporate special items:

Net costs for significant litigation

Divestiture costs

—

—

—

Loss on business divestitures

—

—

Transformation costs

—

—

Total corporate special items

Other corporate (expense) income - net

(8)

Total Corporate and Other

Total company operating income

Other expense/(income), net

Income from continuing operations before income taxes

$

$

$

$

8

3M Company and Subsidiaries

BUSINESS SEGMENTS - (CONTINUED)

(Unaudited)

Corporate and Other

Outside of 3M's reportable operating segments, 3M has Corporate and Other which is not a reportable business segment as it does not meet the segment reporting criteria. Because Corporate and Other includes a variety of miscellaneous items, it is subject to fluctuation on a quarterly and annual basis.

Corporate and Other operating income (loss) includes:

•Corporate special items include, for the periods presented:

◦net costs for significant litigation impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms Earplugs matters,

◦loss on business divestitures,

◦divestiture costs (related to separating and divesting substantially an entire business segment of 3M following public announcement of its intended divestiture) that were not eligible to be part of discontinued operations, and

◦transformation program restructuring and related charges.

•Other corporate (expense) income-net includes:

◦certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs that 3M may choose not to allocate directly to its business segments,

◦commercial activity with Solventum following its April 1, 2024 Separation and certain operations of the former Health Care business segment retained by 3M,

◦transition arrangement agreements (e.g., fees charged by 3M, net of underlying costs) related to divested businesses, including those related to the Solventum Separation,

◦operations of businesses of the former Health Care segment divested prior to the Separation and therefore not reflected as discontinued operations within 3M's financial statements, along with limited-duration supply agreements with previous divestitures, and

◦costs previously allocated to Solventum prior to the Separation that were not eligible to be part of discontinued operations.

9

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES

(Unaudited)

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly titled measures used by other companies.

Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments, it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Other, except as described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items” section. The reconciliations below, therefore, also include impacted segments as applicable.

This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:

GAAP amounts for which a measure adjusted for special items is also provided:

Reasons 3M believes the measure is useful:

•Net sales (and sales change)

Considered, in addition to segment operating performance, in evaluating and managing operations; useful in understanding underlying business performance, provides additional transparency to special items

•Operating income (loss), segment operating income (loss) and operating income (loss) margin (and expansion)

•Income from continuing operations before taxes

•Provision for income taxes and effective tax rate

•Net income from continuing operations

•EPS from continuing operations

Additional non-GAAP measures:

•Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion

Used as indicators of strength and ability to generate cash and as indicator of capital deployment; meaningful as measures of performance

The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES – (CONTINUED)

(Unaudited)

Certain amounts adjusted for special items (non-GAAP measures):

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Operating income

Operating income margin

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

$

%

Adjustments for special items:

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

$

%

Total company

GAAP amounts

$

$

%

$

$

%

$

$

Adjustments for special items:

Net costs for significant litigation

—

Manufactured PFAS products

9

Solventum ownership - change in value

—

—

—

Total special items

Adjusted amounts (non-GAAP measures)3

$

$

%

$

$

%

$

$

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Sales change

Operating income

Operating income margin

Operating income margin expansion

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

EPS percent change

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

%

$

%

Adjustments for special items:

Manufactured PFAS products

2

Adjusted amounts (non-GAAP measures)3

$

%

$

%

Total company

GAAP amounts

$

%

$

%

$

$

%

$

$

%

Adjustments for special items:

Net costs for significant litigation

—

Loss on business divestitures

—

2

Manufactured PFAS products

2

2

1

1

—

Solventum ownership - change in value

—

—

Transformation costs

—

3

Total special items

Adjusted amounts (non-GAAP measures)3

$

%

$

%

$

$

%

$

$

%

3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES

(Unaudited)

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Operating income

Operating income margin

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

$

%

Adjustments for special items:

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

$

%

Total Company

GAAP amounts

$

$

%

$

$

%

$

$

Adjustments for special items:

Net costs for significant litigation

—

Divestiture costs

—

Manufactured PFAS products

7

Pension risk transfer charge

—

—

Solventum ownership - change in value

—

—

—

Total special items

Adjusted amounts (non-GAAP measures)3

$

$

%

$

$

%

$

$

Amounts from continuing operations

(Dollars in millions, except per share amounts)

Net sales

Sales change

Operating income

Operating income margin

Operating income margin expansion

Income before taxes

Provision for income taxes

Effective tax rate

Net income attributable to 3M

EPS

EPS percent change

Safety and Industrial

GAAP amounts

$

%

Adjustments for special items:

Net costs for significant litigation

Adjusted amounts (non-GAAP measures)3

$

%

Transportation and Electronics

GAAP amounts

$

%

$

%

Adjustments for special items:

Manufactured PFAS products

Adjusted amounts (non-GAAP measures)3

$

%

$

%

Total Company

GAAP amounts

$

%

$

%

bps

$

$

%

$

$

%

Adjustments for special items:

Net costs for significant litigation

—

(1)

Loss on business divestitures

—

3

Manufactured PFAS products

Solventum ownership - change in value

—

—

Transformation costs

—

3

Total special items

Adjusted amounts (non-GAAP measures)3

$

%

$

%

bps

$

$

%

$

$

%

2025 adjusted operating income margin expansion (non-GAAP measure)3,4

2025 adjusted earnings per share from continuing operations (non-GAAP measure)3,4

43M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant litigation; projected divestiture gains (losses); divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; transformation costs; and net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance of such information is low.

Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction. Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”.

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES (CONTINUED)

(Unaudited)

Sales change2

Organic sales

Acquisitions

Divestitures

Translation

Total sales change

Total company

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted total company (non-GAAP measures)3

%

—

%

%

%

%

Transportation and Electronics

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted Transportation and Electronics (non-GAAP measures)3

%

—

%

%

%

%

By Geographic Area

Americas

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Americas (non-GAAP measures)3

%

—

%

%

%

%

Asia Pacific

%

—

%

—

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Asia Pacific (non-GAAP measures)3

%

—

%

—

%

—

%

%

Europe, Middle East & Africa

%

—

%

—

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Europe, Middle East & Africa (non-GAAP measures)3

%

—

%

—

%

%

%

By Particular Country

United States

%

—

%

%

—

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted United States (non-GAAP measures)3

%

—

%

%

—

%

%

China

%

—

%

—

%

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted China (non-GAAP measures)3

%

—

%

—

%

%

%

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES (CONTINUED)

(Unaudited)

Sales Change2

Organic sales

Acquisitions

Divestitures

Translation

Total sales change

Total Company

%

—

%

%

—

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted total Company (non-GAAP measures)3

%

—

%

%

—

%

%

Transportation and Electronics

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted Transportation and Electronics (non-GAAP measures)3

%

—

%

%

%

%

By Geographic Area

Americas

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Americas (non-GAAP measures)3

%

—

%

%

%

%

Asia Pacific

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted Asia Pacific (non-GAAP measures)3

%

—

%

%

%

%

Europe, Middle East & Africa

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

—

Adjusted Europe, Middle East & Africa (non-GAAP measures)3

%

—

%

%

%

%

By Particular Country

United States

%

—

%

%

—

%

%

Remove manufactured PFAS products special item impact

—

—

—

Adjusted United States (non-GAAP measures)3

%

—

%

%

—

%

%

China

%

—

%

%

%

%

Remove manufactured PFAS products special item impact

—

Adjusted China (non-GAAP measures)3

%

—

%

%

%

%

Sales Change2

Organic sales

Acquisitions

Divestitures

Translation

Total sales change

Total Company4

>2%

—

%

—

%

Remove manufactured PFAS products impact4

—

—

—

—

—

Adjusted total company (non-GAAP measures)3,4

>2%

—

%

—

%

Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-GAAP measures):

Three months ended

Nine months ended

Major GAAP cash flow categories (dollars in millions)

Net cash provided by (used in) operating activities

$

$

$

$

1

Net cash provided by (used in) investing activities

Net cash provided by (used in) financing activities

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES (CONTINUED)

(Unaudited)

Three months ended

Nine months ended

Adjusted free cash flow (non-GAAP measure) (dollars in millions)

Net cash provided by (used in) operating activities

$

$

$

$

1

Adjustments for special items:

Net costs/(recoveries) for significant litigation after-tax payment impacts

Divestiture costs after-tax payment impacts

Divestiture-related restructuring after-tax payment impacts

—

—

—

2

TCJA transition tax payment

—

—

Manufactured PFAS products after-tax payment impacts

Total adjustments for special items

Adjusted net cash provided by (used in) operating activities (non-GAAP measure)5

$

$

$

$

Purchases of property, plant and equipment (PPE)

Manufactured PFAS products impact - removing related purchases of PPE

6

Adjusted purchases of PPE (non-GAAP measure)5

$

$

$

$

Adjusted free cash flow (non-GAAP measure)5

$

$

$

$

Net income attributable to 3M

$

$

$

$

Adjustments for special items, net of tax:

Net costs for significant litigation

Manufactured PFAS products impact

1

Loss on business divestitures

—

—

Divestiture costs

—

—

—

Solventum ownership - change in value

Pension risk transfer charge

—

—

—

Transformation costs

—

—

Total adjustments for special items, net of tax

Net income attributable to 3M adjusted for special items

(used for adjusted free cash flow conversion calculation)

$

$

$

$

Adjusted free cash flow conversion (non-GAAP measure)5

%

%

%

%

53M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations (Solventum separated from 3M in April 2024); accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued operations in certain periods both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash provided by (used in) operating activities less adjusted purchases of PPE.

Cash payments/receipts associated with special items in the determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the portion of payments of costs for significant litigation under the 2023 and 2025 settlement/proposed settlement agreements relative to Combat Arms Earplugs and relative to public water suppliers and the state of New Jersey regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the pre-tax cash settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax payments relative to underlying Separation transactions.

For other special items, the cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. Tax impacts include associated impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for special items (used for adjusted free cash flow conversion calculation).

3M Company and Subsidiaries

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP MEASURES (CONTINUED)

(Unaudited)

(Dollars in billions)

Net cash provided by (used in) operating activities